OTTO CHRISTIANE DR DR
No ORCID on file
· 9 papers in corpus
· active 2011
Frequent coauthors
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…
2011
The present invention is directed to neutralizing prolactin receptor antibodies and antigen binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications medi…